Physician
Kash, Virginia
Kash, Virginia was paid $269K by Medicaid between Jan 2018 and Dec 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 36% of everything it billed.
33Billing provider infoKASH, VIRGINIA
NAPERVILLE, IL 60563
NAPERVILLE, IL 60563
33aNPI1962402958assigned 07/30/2005
33bProvider typePediatrics Physician
28Total paid$269K
24GClaims5,350
24DCodes billed26
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#455 of 1,805
Median peer was paid$55K
This provider vs. median4.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 183 | $8K | |
| 2019 | 397 | $23K | |
| 2020 | 266 | $11K | |
| 2021 | 562 | $25K | |
| 2022 | 1,182 | $60K | |
| 2023 | 1,095 | $62K | |
| 2024incomplete | 1,665 | $80K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 36% | 1,225 | 1,115 | $97K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 1,754 | 1,555 | $87K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 12% | 223 | 194 | $31K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.2% | 113 | 105 | $9K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.8% | 323 | 306 | $8K |
| 96160 | 2.3% | 425 | 302 | $6K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.8% | 57 | 46 | $5K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.2% | 43 | 32 | $3K |
| 92551 | 1.2% | 220 | 177 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.2% | 77 | 65 | $3K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 85 | 57 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 115 | 79 | $3K |
14 more codes
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 31 | $2K |
| 96127 | <1% | 77 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 29 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 26 | $1K |
| 90686 | <1% | 103 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 58 | $932.52 |
| 90674 | <1% | 37 | $618.27 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 35 | $511.00 |
| 85018 | <1% | 168 | $387.86 | |
| 90661 | <1% | 23 | $384.33 | |
| 90671 | <1% | 21 | $350.91 | |
| 90698 | <1% | 21 | $350.91 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $251.20 |
| 36416 | <1% | 45 | $184.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.